ACB / Aurora Cannabis Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS OF AURORA CANNABIS INC. (the “Company”) August 8, 2025 REPORT OF VOTING RESULTS Pursuant to Section 11.3 of National Instrument 51-102 Continuous Disclosure Obligations (“NI 51-102”)

Exhibit 99.1 ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS OF AURORA CANNABIS INC. (the “Company”) August 8, 2025 REPORT OF VOTING RESULTS Pursuant to Section 11.3 of National Instrument 51-102 Continuous Disclosure Obligations (“NI 51-102”) In accordance with section 11.3 of NI 51-102 and following the annual general and special meeting of the holders of common shares (“Shares”) of the Compa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File No. 001-38691 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive o

Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting

Exhibit 99.1 Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting NASDAQ | TSX: ACB EDMONTON, AB, Aug. 8, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") hel

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File No. 001-38691 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File No. 001-38691 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive o

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “inter

a993certificationofceo 1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File No. 001-38691 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive o

AURORA CANNABIS INC. Management’s Discussion & Analysis First Quarter 2026 For the three months ended June 30, 2025 (in Canadian Dollars)

AURORA CANNABIS INC. Management’s Discussion & Analysis First Quarter 2026 For the three months ended June 30, 2025 (in Canadian Dollars) 1 | AURORA CANNABIS INC. Q1 2026 MD&A Interim Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three months ended June 30, 2025 This Management’s Discussion and Analysis (“MD&A”) of Aurora Cannabis Inc. (“Aurora” or t

Aurora Cannabis Announces Fiscal 2026 First Quarter Results

Exhibit 99.1 Aurora Cannabis Announces Fiscal 2026 First Quarter Results NASDAQ | TSX: ACB • Expands YoY Global Medical Cannabis Net Revenue1 by 37% to $64.8 million, while increasing International Medical Cannabis Net Revenue1 by 85% to $37.1 million • Delivers Adjusted EBITDA1 growth in excess of 200%, reaching $10.8 million • Generates Positive Free Cash Flow1 of $9.2 million, representing sign

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Simona King, Chief Financial Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim

a994certificationofcfo 1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Simona King, Chief Financial Officer of Aurora Cannabis Inc.

AURORA CANNABIS INC. Interim Condensed Consolidated Financial Statements For the three months ended June 30, 2025 and 2024 (in Canadian Dollars)

AURORA CANNABIS INC. Interim Condensed Consolidated Financial Statements (Unaudited) For the three months ended June 30, 2025 and 2024 (in Canadian Dollars) AURORA CANNABIS INC. Interim Condensed Consolidated Statements of Financial Position (Unaudited) ($ thousands) Note June 30, 2025 March 31, 2025 $ $ Assets Current assets Cash and cash equivalents 140,160 137,921 Restricted cash 9, 2(c) 45,873

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

YOUR VOTE IS IMPORTANT NO MATTER HOW MANY SHARES YOU HOLD. THE BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE FOR ALL DIRECTOR NOMINEES AND PROPOSED RESOLUTIONS

Exhibit 99.1 Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2025 Annual General and Special Meeting of Shareholders Your vote is important no matter how many shares you own. Please vote today. Shareholders who have questions or need assistance with voting their shares should contact Aurora's strategic advisor and proxy solicitation agent, Laurel H

Aurora Cannabis to Host First Quarter 2026 Investor Conference Call

Exhibit 99.1 Aurora Cannabis to Host First Quarter 2026 Investor Conference Call NASDAQ | TSX: ACB EDMONTON, AB, July 23, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2026 on Wednesday, August 6,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

Aurora Completes First-Ever EU-GMP Certification for the Company's Dedicated Distribution Centre Adding a fourth certified facility within its global network increases operational capacity to better serve international medical markets

Exhibit 99.1 Aurora Completes First-Ever EU-GMP Certification for the Company's Dedicated Distribution Centre Adding a fourth certified facility within its global network increases operational capacity to better serve international medical markets NASDAQ | TSX: ACB EDMONTON, AB, July 14, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

YOUR VOTE IS IMPORTANT. VOTE YOUR SHARES FOR AURORA'S DIRECTOR NOMINEES AND MEETING RESOLUTIONS AS SOON AS POSSIBLE

Exhibit 99.1 Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders • Your vote is important no matter how many shares you own. Please vote today. • Shareholders who have questions or need assistance with voting their shares should contact Aurora's strategic advisor and proxy solicitation ag

FORM OF PROXY

Exhibit 99.2

Bios can be found here: https://www.auroramj.com/about-us/#leadership

Exhibit 99.1 Letter from our Executive Chairman and CEO Dear Fellow Shareholders, We are pleased to invite you to the 2025 Annual General and Special Meeting of Shareholders of Aurora Cannabis Inc. (“Aurora” or the “Company”) to be held virtually on Friday, August 8, 2025 at 1:00 pm Eastern Time (the “Meeting”). As a Canadian headquartered company, with a substantial number of our shareholders res

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

Notice of Annual General and Special Meeting of Shareholders and Availability of Proxy Materials

Exhibit 99.3 Notice of Annual General and Special Meeting of Shareholders and Availability of Proxy Materials To vote you must follow the methods reflected on your enclosed Voting Instruction Form (“VIF”) or Form of Proxy (“Proxy”) BEFORE 1:00 p.m. Eastern Time on Wednesday, August 6, 2025 (or such earlier time specified in the VIF by the intermediary holding your shares) MEETING DATE AND LOCATION

VIRTUAL AGM USER GUIDE

Exhibit 99.4

Aurora Cannabis Advises of Second False Article from Investing.com

Exhibit 99.1 Aurora Cannabis Advises of Second False Article from Investing.com NASDAQ | TSX: ACB EDMONTON, AB, June 19, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has become aware of a second instance of misinformation posted on news website, Investing.com. On June 18, 2025, Aurora advised the mar

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

CERTIFICATION I, Miguel Martin, certify that: 1. I have reviewed this annual report on Form 40-F of Aurora Cannabis Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact

a991-s302certificationc CERTIFICATION I, Miguel Martin, certify that: 1. I have reviewed this annual report on Form 40-F of Aurora Cannabis Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit

CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Aurora Cannabis Inc. (the “Company”) on Form 40-F for the period ended March 31, 2025 as filed wit

CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Aurora Cannabis Inc. (the “Company”) on Form 40-F for the period ended March 31, 2025 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Miguel Martin, Chief Executive Officer of the Company, certify, pursuan

Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter

Exhibit 99.1 Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter NASDAQ | TSX: ACB Achieves Record Annual Global Medical Cannabis Net Revenue1 of $244.4 million, representing 39% YoY growth Delivers Record Adjusted EBITDA1 of $49.7 million, representing 261% YoY growth Generates Annual Positive Free Cash Flow1 of $9.9 million Sustains Strong Balance Sheet with ~$185.3

Consent of Independent Registered Public Accounting Firm The Board of Directors Aurora Cannabis Inc. We consent to the use of our report dated June 17, 2025 on the consolidated financial statements of Aurora Cannabis Inc. (the “Entity”), which compri

Consent of Independent Registered Public Accounting Firm The Board of Directors Aurora Cannabis Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

Consent of Independent Registered Public Accounting Firm We consent to the reference to our Firm under the caption “Experts”, and to the incorporation by reference in the Registration Statements on Form S-8 no. 333-282253 and Form F-10 no. 333-284958

Consent of Independent Registered Public Accounting Firm We consent to the reference to our Firm under the caption “Experts”, and to the incorporation by reference in the Registration Statements on Form S-8 no.

CERTIFICATION I, Simona King, certify that: 1. I have reviewed this annual report on Form 40-F of Aurora Cannabis Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact ne

CERTIFICATION I, Simona King, certify that: 1. I have reviewed this annual report on Form 40-F of Aurora Cannabis Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period co

CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Aurora Cannabis Inc. (the “Company”) on Form 40-F for the period ended March 31, 2025 as filed wit

CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Aurora Cannabis Inc. (the “Company”) on Form 40-F for the period ended March 31, 2025 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Simona King, Chief Financial Officer of the Company, certify, pursuant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the financial year ended March 31, 2025 Commission File Number: 001-38691 AURORA CANNABIS INC. (Exact name of Registrant as specified in

Cannabis Pioneers. Industry Leaders ANNUAL INFORMATION FORM For the financial year ended March 31, 2025 June [11], 2025 {00269672:2} Annual Information Form For the year ended March 31, 2025 June 17, 2025 1 | P a g e WHAT’S INSIDE: FORWARD-LOOKING ST

Cannabis Pioneers. Industry Leaders ANNUAL INFORMATION FORM For the financial year ended March 31, 2025 June [11], 2025 {00269672:2} Annual Information Form For the year ended March 31, 2025 June 17, 2025 1 | P a g e WHAT’S INSIDE: FORWARD-LOOKING STATEMENTS .............................................................................. 2 CORPORATE STRUCTURE ........................................

AURORA CANNABIS INC. Consolidated Financial Statements For the years ended March 31, 2025 and 2024 (in Canadian Dollars)

AURORA CANNABIS INC. Consolidated Financial Statements For the years ended March 31, 2025 and 2024 (in Canadian Dollars) Table of Contents Consolidated Statements of Financial Position 9 Consolidated Statements of Income (loss) and Comprehensive Income (loss) 10 Consolidated Statements of Changes in Equity 12 Consolidated Statements of Cash Flows 14 Notes to the Consolidated Financial Statements N

AURORA CANNABIS INC. Management’s Discussion & Analysis For the years ended March 31, 2025 and 2024 (in Canadian Dollars)

AURORA CANNABIS INC. Management’s Discussion & Analysis For the years ended March 31, 2025 and 2024 (in Canadian Dollars) Management’s Discussion & Analysis Table of Contents Business Overview 3 Condensed Statement of Comprehensive Income (Loss) 5 Key Quarterly Financial Results 6 Key Developments During and Subsequent to Three Months Ended March 31, 2025 6 Financial Review 7 Liquidity and Capital

Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics

Exhibit 99.1 Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics NASDAQ | TSX: ACB EDMONTON, AB, June 18, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has become aware of misinformation posted on a news website, incorrectly stating that Aurora has agreed to acquire New Zealand based Me

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information

Exhibit 99.1 Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information NASDAQ | TSX: ACB EDMONTON, AB, June 3, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the resul

510 Burrard St, 3rd

Exhibit 99.1 Date: May 22, 2025 510 Burrard St, 3rd Floor Vancouver BC, V6C 3B9 www.computershare.com To: All Canadian Securities Regulatory Authorities Subject: AURORA CANNABIS INC. Dear Sir/Madam: We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: Meeting Type : Annual General and Special Meeting Record Date for Notice of Meeting : June 16

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File No. 001-38691 AURO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive offi

Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars

Exhibit 99.1 Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars NASDAQ | TSX: ACB Groundbreaking research at Aurora Coast, Aurora's world-class research and development facility, sets new standard in cannabis science EDMONTON, AB, March 20, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File No. 001-38691 AU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive of

Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia

Exhibit 99.1 Breaking Down Barriers: Aurora Cannabis Eases Patient Access to High Quality Medical Cannabis Products in Australia NASDAQ | TSX: ACB Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia EDMONTON, AB, Feb. 14, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive

PROSPECTUS SUPPLEMENT TO THE SHORT FORM BASE SHELF PROSPECTUS DATED FEBRUARY 14, 2025 New Issue February 14, 2025 AURORA CANNABIS INC. 7,040,875 Common Shares

Table of Contents Filed pursuant to General Instruction II.L of Form F-10; File No. 333-284958 PROSPECTUS SUPPLEMENT TO THE SHORT FORM BASE SHELF PROSPECTUS DATED FEBRUARY 14, 2025 New Issue February 14, 2025 AURORA CANNABIS INC. 7,040,875 Common Shares This Prospectus Supplement relates to: (i) up to 7,040,875 common shares (the “Warrant Shares”) of Aurora Cannabis Inc. (“we”, “our”, “Aurora” or

FORM 51-102F3 MATERIAL CHANGE REPORT

Exhibit 4.8 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Aurora Cannabis Inc. (“Aurora” or the “Company”) 2207-90b Street SW Edmonton, Alberta T6X 1V8 Item 2 Date of Material Change February 6, 2025 Item 3 News Release A press release describing the material change was disseminated by Aurora on February 6, 2025 through Cision PR Newswire and can be found on SEDAR+ at www

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE

Exhibit 7.2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) Na

As filed with the Securities and Exchange Commission on February 14, 2025

As filed with the Securities and Exchange Commission on February 14, 2025 Registration No.

CALCULATION OF FILING FEE TABLES Form F-10 (Form Type) Aurora Cannabis Inc. (Exact Name of Registrant as Specified in its Charter) Table 3: Combined Prospectuses In US Dollars Security Type Security Class Title Amount of Securities Previously Registe

Exhibit 107 CALCULATION OF FILING FEE TABLES Form F-10 (Form Type) Aurora Cannabis Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. Name of issuer or person filing (“Filer”): Aurora Cannabis Inc. B. (1)   This is [check one]: ☒   an origi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. Name of issuer or person filing (“Filer”): Aurora Cannabis Inc. B. (1)   This is [check one]: ☒   an original filing for the Filer ☐   an amended filing for the Filer (2)   Check the following box if you are filing the Form F-X in paper in accordance with

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive

Agreement Complements Existing Relationship Focused on the Supply of Premium Cannabis

Exhibit 99.1 Aurora Cannabis Announces Supply Agreement with SNDL NASDAQ | TSX: ACB Agreement Complements Existing Relationship Focused on the Supply of Premium Cannabis EDMONTON, AB, February 6, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to announce a strategic supply agreement (the

Aurora Cannabis Announces Fiscal 2025 Third Quarter Results

Exhibit 99.1 Aurora Cannabis Announces Fiscal 2025 Third Quarter Results NASDAQ | TSX: ACB Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1 Million in Global Medical Cannabis, up 51% YoY Generates Record Net Income of $31.2 Million, up 282% YoY, and Record Adjusted EBITDA1 of $23.1 Million, up 316% YoY Achieves Target of Positive Free Cash Flow1 in Q3

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Simona King, Chief Financial Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim

a994certificationofcfo 1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Simona King, Chief Financial Officer of Aurora Cannabis Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive

AURORA CANNABIS INC. Management’s Discussion & Analysis For the three and nine months ended December 31, 2024 and 2023 (in Canadian Dollars)

AURORA CANNABIS INC. Management’s Discussion & Analysis For the three and nine months ended December 31, 2024 and 2023 (in Canadian Dollars) Management’s Discussion & Analysis Table of Contents Business Overview 3 Condensed Statement of Comprehensive Income (Loss) 5 Key Quarterly Financial Results 6 Key Developments During and Subsequent to Three Months Ended December 31, 2024 6 Financial Review 7

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “inter

a993certificationofceo 1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc.

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements For the three and nine months ended December 31, 2024 and 2023 (in Canadian Dollars)

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and nine months ended December 31, 2024 and 2023 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Income (Loss) 4 Condensed Consolidated Interim Statements of Changes

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive

Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call

Exhibit 99.1 Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call NASDAQ | TSX: ACB EDMONTON, AB, Jan. 22, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2025 on Wednesday, February 5

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “inter

a993certificationofceo 1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc.

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Simona King, Chief Financial Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim

a994certificationofcfo 1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Simona King, Chief Financial Officer of Aurora Cannabis Inc.

Aurora Cannabis Announces Fiscal 2025 Second Quarter Results

Exhibit 99.1 Aurora Cannabis Announces Fiscal 2025 Second Quarter Results NASDAQ | TSX: ACB Record Adjusted EBITDA1 of $10.1 Million, a YoY increase of 210% Quarterly Net Revenue1 up 29% YoY to $81.1 Million, with 41% growth in Global Medical Cannabis Re-Affirms Target of Positive Free Cash Flow1 in the Quarter Ending December 31, 2024 Maintains Strong Balance Sheet with ~$152 Million of Cash and

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive o

AURORA CANNABIS INC. Management’s Discussion & Analysis For the three and six months ended September 30, 2024 and 2023 (in Canadian Dollars)

AURORA CANNABIS INC. Management’s Discussion & Analysis For the three and six months ended September 30, 2024 and 2023 (in Canadian Dollars) Management’s Discussion & Analysis Table of Contents Business Overview 3 Condensed Statement of Comprehensive Loss 5 Key Quarterly Financial Results 6 Key Developments During and Subsequent to Three Months Ended September 30, 2024 6 Financial Review 7 Liquidi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements For the three and six months ended September 30, 2024 and 2023 (in Canadian Dollars)

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and six months ended September 30, 2024 and 2023 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Loss and Comprehensive Loss 4 Condensed Consolidated Interim Statements of Changes in Equity 6 Conden

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive

Aurora Cannabis to Host Second Quarter 2025 Investor Conference Call

Exhibit 99.1 Aurora Cannabis to Host Second Quarter 2025 Investor Conference Call NASDAQ | TSX: ACB EDMONTON, AB, Oct. 24, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today announced today that it has scheduled a conference call to discuss the results for its second quarter 2025 on Wed

BUSINESS CORPORATIONS ACT (British Columbia) AURORA CANNABIS INC. (the “Company”) TABLE OF CONTENTS PART 1 INTERPRETATION 1 PART 2 SHARES AND SHARE CERTIFICATES 2 PART 3 ISSUE OF SHARES 4 PART 4 SHARE REGISTERS 5 PART 5 SHARE TRANSFERS 5 PART 6 TRANS

EX-4.1 Exhibit 4.1 Previous Articles are cancelled and current Articles are adopted by special resolution of the Shareholders on November 30, 2018 and received for deposit on December 18, 2018 at 3:15 PM Pacific Time.     Incorporation number: BC0777982 BUSINESS CORPORATIONS ACT (British Columbia) ARTICLES of AURORA CANNABIS INC. (the “Company”) TABLE OF CONTENTS PART 1 INTERPRETATION 1 PART 2 SHA

Calculation of Filing Fee Table (Form Type) Aurora Cannabis Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximu

EX-FILING FEES EXHIBIT 107 Calculation of Filing Fee Table S-8 (Form Type) Aurora Cannabis Inc.

Aurora Cannabis Inc. 2024 Restricted Share Unit Plan Section 10(a) Prospectus

EX-4.5 Exhibit 4.5 Aurora Cannabis Inc. 2024 Restricted Share Unit Plan Section 10(a) Prospectus This prospectus (this “Prospectus”) relates to the registration of common shares (the “Common Shares”) of Aurora Cannabis Inc. (the “Company”), which are reserved for issuance to directors, officers, employees and consultants of the Company and its subsidiaries (the “Participants”) under the Aurora Can

Aurora Cannabis Inc. 2024 Share Option Plan Section 10(a) Prospectus

EX-4.2 Exhibit 4.2 Aurora Cannabis Inc. 2024 Share Option Plan Section 10(a) Prospectus This prospectus (this “Prospectus”) relates to the registration of common shares (the “Common Shares”) of Aurora Cannabis Inc. (the “Company”), which are reserved for issuance to directors, officers, employees and consultants of the Company and its subsidiaries (the “Participants”) under the Aurora Cannabis Inc

Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition

Exhibit 99.1 Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors NASDAQ | TSX: ACB Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition EDMONTON, AB, Sept. 20, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, toda

Aurora Cannabis Inc. 2024 Deferred Share Unit Plan Section 10(a) Prospectus

EX-4.3 Exhibit 4.3 Aurora Cannabis Inc. 2024 Deferred Share Unit Plan Section 10(a) Prospectus This prospectus (this “Prospectus”) relates to the registration of common shares (the “Common Shares”) of Aurora Cannabis Inc. (the “Company”), which are reserved for issuance to non-employee directors of the Company and its subsidiaries (the “Participants”) under the Aurora Cannabis Inc. 2024 Deferred S

As filed with the Securities and Exchange Commission on September 20, 2024

S-8 As filed with the Securities and Exchange Commission on September 20, 2024 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File No. 001-3869

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executiv

Aurora Cannabis Inc. 2024 Performance Share Unit Plan Section 10(a) Prospectus

EX-4.4 Exhibit 4.4 Aurora Cannabis Inc. 2024 Performance Share Unit Plan Section 10(a) Prospectus This prospectus (this “Prospectus”) relates to the registration of common shares (the “Common Shares”) of Aurora Cannabis Inc. (the “Company”), which are reserved for issuance to officers, employees and consultants of the Company and its subsidiaries (the “Participants”) under the Aurora Cannabis Inc.

Auto-Flowering Breakthroughs Poised to Transform Cannabis Cultivation in High-Latitude Regions, Opening New Doors for Advanced Breeding Strategies

Exhibit 99.1 Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence Auto-Flowering Breakthroughs Poised to Transform Cannabis Cultivation in High-Latitude Regions, Opening New Doors for Advanced Breeding Strategies EDMONTON, AB, Sept. 17, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File No. 001-3869

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executiv

FORM 51-102F3 MATERIAL CHANGE REPORT

Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Aurora Cannabis Inc. (“Aurora” or the “Company”) 2207-90b Street SW Edmonton, Alberta T6X 1V8 Item 2 Date of Material Change July 31, 2024 Item 3 News Release A press release describing the material change was disseminated by Aurora before market open on August 1, 2024 through Cision PR Newswire and can be found o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive o

Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting

EX-99.1 2 ex991.htm NEWS RELEASE DATED AUGUST 12, 2024 Exhibit 99.1 Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting NASDAQ | TSX: ACB EDMONTON, AB, Aug. 12, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and

ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS OF AURORA CANNABIS INC. (the “Company”) August 9, 2024 REPORT OF VOTING RESULTS Pursuant to Section 11.3 of National Instrument 51-102 Continuous Disclosure Obligations (“NI 51-102”)

Exhibit 99.2 ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS OF AURORA CANNABIS INC. (the “Company”) August 9, 2024 REPORT OF VOTING RESULTS Pursuant to Section 11.3 of National Instrument 51-102 Continuous Disclosure Obligations (“NI 51-102”) In accordance with section 11.3 of NI 51-102 and following the annual general and special meeting of the holders of common shares (“Shares”) of the Compa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive o

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements For the three months ended June 30, 2024 and 2023 (in Canadian Dollars)

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three months ended June 30, 2024 and 2023 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Income (Loss) 4 Condensed Consolidated Interim Statements of Changes in Equity 6 C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive o

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “inter

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc.

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Simona King, Chief Financial Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Simona King, Chief Financial Officer of Aurora Cannabis Inc.

AURORA CANNABIS INC. Management’s Discussion & Analysis For the three months ended June 30, 2024 and 2023 (in Canadian Dollars)

AURORA CANNABIS INC. Management’s Discussion & Analysis For the three months ended June 30, 2024 and 2023 (in Canadian Dollars) Management’s Discussion & Analysis Table of Contents Business Overview 3 Condensed Statement of Comprehensive Loss 5 Key Quarterly Financial Results 6 Key Developments During and Subsequent to Three Months Ended June 30, 2024 6 Financial Review 7 Liquidity and Capital Res

Aurora Cannabis Announces Fiscal 2025 First Quarter Results and Delivers Positive Free Cash Flow

Exhibit 99.1 Aurora Cannabis Announces Fiscal 2025 First Quarter Results and Delivers Positive Free Cash Flow Delivers Positive Free Cash Flow1 of $6.5 Million Increases Total Quarterly Net Revenue1 by 12% YoY to $83.4 Million, Record Net Revenue1 of $47.2 Million in Global Medical Cannabis Generates Adjusted EBITDA1 of $4.9 Million, a YoY increase of 87% Ends the Fiscal Quarter with a Debt-Free C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive o

Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration Collaboration will initially see launch of a new CBD lozenge from Cogent International, a Vectura Fertin Pharma subsidiary, on Aurora's Canadian medical cannabis patien

Exhibit 99.1 Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration Collaboration will initially see launch of a new CBD lozenge from Cogent International, a Vectura Fertin Pharma subsidiary, on Aurora's Canadian medical cannabis patient platform Following successful launch of CBD lozenge, the collaboration will explore the potential to launch Vectura Fertin Pharma's fut

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

Aurora Cannabis to Host First Quarter 2025 Investor Conference Call

Exhibit 99.1 Aurora Cannabis to Host First Quarter 2025 Investor Conference Call NASDAQ | TSX: ACB EDMONTON, AB, July 29, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2025 on Wednesday, August 7, 2024

Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility Company’s Long-Standing Investment in the Region Continues with Enhanced Local Production and Domestic Cultivar Research

EXHIBIT 99.1 July 25, 2024 NASDAQ | TSX: ACB Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility Company’s Long-Standing Investment in the Region Continues with Enhanced Local Production and Domestic Cultivar Research Edmonton, AB – July 25, 2024 – Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ | TSX: ACB), a leading Canadian-based global medical cannabi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility

Exhibit 99.1 Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility NASDAQ | TSX: ACB Company's Long-Standing Investment in the Region Continues with Enhanced Local Production and Domestic Cultivar Research EDMONTON, AB, July 25, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canadian-based global medical cannabis co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

Aurora Cannabis Inc. Announces Filing and Mailing of Management Information Circular in Connection with Upcoming Annual General and Special Meeting of Shareholders

Exhibit 99.1 Aurora Cannabis Inc. Announces Filing and Mailing of Management Information Circular in Connection with Upcoming Annual General and Special Meeting of Shareholders NASDAQ | TSX: ACB Your vote is important no matter how many shares you own. Please vote today. Shareholders with questions or who need assistance voting their shares should contact Aurora's strategic advisor and proxy solic

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

EX-99.4

Exhibit 99.4

CEO Letter to Shareholders

Exhibit 99.1 CEO Letter to Shareholders Dear Shareholders, We are pleased to invite you to the 2024 Annual General and Special Meeting of Shareholders of Aurora Cannabis Inc. (“Aurora” or the “Company”) to be held on Friday, August 9, 2024 at 1:00 pm Eastern Time (the “Meeting”). We are holding the Meeting in a virtual-only format once again in order to give our shareholders an equal opportunity t

Beneficial Shareholders Shares held with a broker, bank or other intermediary

Exhibit 99.3 Notice of Annual General and Special Meeting of Shareholders and Availability of Proxy Materials To vote you must follow the methods reflected on your enclosed Voting Instruction Form (“VIF”) or Form of Proxy (“Proxy”) BEFORE 1:00 p.m. Eastern Time on Wednesday, August 7, 2024 (or such earlier time specified in the VIF by the intermediary holding your shares) MEETING DATE AND LOCATION

EX-99.5

Exhibit 99.5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

EX-99.2

Exhibit 99.2

AURORA CANNABIS INC. NOTICE OF CHANGE OF AUDITOR

Exhibit 99.1 AURORA CANNABIS INC. NOTICE OF CHANGE OF AUDITOR TO: Ernst & Young LLP 1133 Melville Street, Suite 1900 Vancouver, BC V6E 4E5 AND TO: KPMG LLP PO Box 10426, 777 Dunsmuir Street Vancouver, BC V7Y 1K3 AND TO: Alberta Securities Commission British Columbia Securities Commission Manitoba Securities Commission Saskatchewan Financial Services Commission Ontario Securities Commission Autorit

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

PO Box 10426 777 Dunsmuir Street

Exhibit 99.3 KPMG LLP PO Box 10426 777 Dunsmuir Street Vancouver BC V7Y 1K3 Canada Telephone (604) 691-3000 Fax (604) 691-3031 Alberta Securities Commission British Columbia Securities Commission Manitoba Securities Commission Saskatchewan Financial Services Commission Ontario Securities Commission Autorité des marchés financiers Financial and Consumer Services Commission (New Brunswick) Office of

June 26,

Exhibit 99.2 June 26, 2024 Alberta Securities Commission British Columbia Securities Commission Manitoba Securities Commission Saskatchewan Financial Services Commission Ontario Securities Commission Autorité des marchés financiers Financial and Consumer Services Commission (New Brunswick) Office of the Superintendent of Securities Service, Newfoundland and Labrador Nova Scotia Securities Commissi

{00269672:2} Responsible Growth Toward Bold New Horizons ANNUAL INFORMATION FORM For the financial year ended March 31, 2024 June 20, 2024 1 | P a g e WHAT’S INSIDE: FORWARD-LOOKING STATEMENTS .........................................................

a9972024aif {00269672:2} Responsible Growth Toward Bold New Horizons ANNUAL INFORMATION FORM For the financial year ended March 31, 2024 June 20, 2024 1 | P a g e WHAT’S INSIDE: FORWARD-LOOKING STATEMENTS .

AURORA CANNABIS INC. Management’s Discussion & Analysis For the year ended March 31, 2024 and nine months ended March 31, 2023 (in Canadian Dollars)

AURORA CANNABIS INC. Management’s Discussion & Analysis For the year ended March 31, 2024 and nine months ended March 31, 2023 (in Canadian Dollars) Management’s Discussion & Analysis Table of Contents Business Overview 3 Condensed Statement of Comprehensive Loss 5 Key Quarterly Financial and Operating Results 7 Key Developments During and Subsequent to Three Months Ended March 31, 2024 8 Financia

CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Aurora Cannabis Inc. (the “Company”) on Form 40-F for the period ended March 31, 2024 as filed wit

a993-s906certificationce CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Aurora Cannabis Inc. (the “Company”) on Form 40-F for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Miguel Martin, Chief Executive Officer of the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 x ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 x ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the financial year ended March 31, 2024 Commission File Number: 001-38691 AURORA CANNABIS INC. (Exact name of Registrant as specified in

{00254172:1} Page 1 AURORA CANNABIS INC. (the “Company”) CLAWBACK POLICY The Human Resources and Compensation Committee (the “HRCC”) of the Board of Directors (“Board”) of the Company has adopted this Clawback Policy (the “Policy”) in accordance with

a97clawbackpolicy {00254172:1} Page 1 AURORA CANNABIS INC. (the “Company”) CLAWBACK POLICY The Human Resources and Compensation Committee (the “HRCC”) of the Board of Directors (“Board”) of the Company has adopted this Clawback Policy (the “Policy”) in accordance with Nasdaq listing requirements effective as of the 1st day of October, 2023. 1. Application of Policy This Policy applies in the event

CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Aurora Cannabis Inc. (the “Company”) on Form 40-F for the period ended March 31, 2024 as filed wit

a994-s906certificationcf CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Aurora Cannabis Inc. (the “Company”) on Form 40-F for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Simona King, Chief Financial Officer of the Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

CERTIFICATION I, Simona King, certify that: 1. I have reviewed this annual report on Form 40-F of Aurora Cannabis Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact ne

a992-s302certificationc CERTIFICATION I, Simona King, certify that: 1. I have reviewed this annual report on Form 40-F of Aurora Cannabis Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with

AURORA CANNABIS INC. Consolidated Financial Statements For the year ended March 31, 2024 and nine months ended March 31, 2023 (in Canadian Dollars)

AURORA CANNABIS INC. Consolidated Financial Statements For the year ended March 31, 2024 and nine months ended March 31, 2023 (in Canadian Dollars) Management’s Responsibility To the Shareholders of Aurora Cannabis Inc.: Management is responsible for the preparation and presentation of the consolidated financial statements and accompanying note disclosures in accordance with International Financia

Consent of Independent Registered Public Accounting Firm The Board of Directors Aurora Cannabis Inc. We consent to the use of: • our report dated June 19, 2024 on the consolidated financial statements of Aurora Cannabis Inc. (the “Entity”) which comp

a998acb202440-fconsent Consent of Independent Registered Public Accounting Firm The Board of Directors Aurora Cannabis Inc.

CERTIFICATION I, Miguel Martin, certify that: 1. I have reviewed this annual report on Form 40-F of Aurora Cannabis Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact

a991-s302certificationc CERTIFICATION I, Miguel Martin, certify that: 1. I have reviewed this annual report on Form 40-F of Aurora Cannabis Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit

Delivers Record Annual Adjusted EBITDA1 of $12.8 Million

Exhibit 99.1 Aurora Cannabis Files Full Year Results and Announces Fiscal 2024 Fourth Quarter Delivers Record Annual Adjusted EBITDA1 of $12.8 Million NASDAQ | TSX: ACB • Q4 Represents the Sixth Consecutive Quarter of Positive Adjusted EBITDA1 • Increased Total Quarterly Net Revenue 5% YoY to $67.4 Million, Global Medical Cannabis Net Revenue1 Grew by 20% YoY to $45.6 Million • Ended the Fiscal Ye

Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2024 Investor Conference Call and File Related Year End Information

Exhibit 99.1 Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2024 Investor Conference Call and File Related Year End Information NASDAQ | TSX: ACB EDMONTON, AB, June 7, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, announced today that it has scheduled a conference call to discuss the results f

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive off

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File No. 001-38691 AURO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive offi

May 24,

Exhibit 99.1 May 24, 2024 510 Burrard St, 3rd Floor Vancouver BC, V6C 3B9 www.computershare.com To: All Canadian Securities Regulatory Authorities Nasdaq Subject: AURORA CANNABIS INC. Dear Sir/Madam: We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: Meeting Type : Annual General and Special Meeting Record Date for Notice of Meeting : June 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File No. 001-38691 AURO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive office

Newly created directorship to be filled by Rajesh Uttamchandani

Exhibit 99.1 Aurora Cannabis Announces Appointment of New Director NASDAQ | TSX: ACB Newly created directorship to be filled by Rajesh Uttamchandani EDMONTON, AB, May 15, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today the appointment of Rajesh Uttamchandani to the Company's Board of

Canada's Leading Medical Cannabis Company Launches Premium Products Redefining Patient Care

Exhibit 99.1 Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market NASDAQ | TSX: ACB Canada's Leading Medical Cannabis Company Launches Premium Products Redefining Patient Care EDMONTON, AB, May 8, 2024 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) the Canadian based leading global medical cannabis company, is proud to announce the arrival of Aurora branded medical cann

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File No. 001-38691 AURO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive office

KPMG LLP

EX-99.2 Exhibit 99.2 KPMG LLP PO Box 10426 777 Dunsmuir Street Vancouver BC V7Y 1K3 Canada Telephone (604) 691-3000 Fax (604) 691-3031 Alberta Securities Commission British Columbia Securities Commission Manitoba Securities Commission Saskatchewan Financial Services Commission Ontario Securities Commission Autorité des marchés financiers Financial and Consumer Services Commission (New Brunswick) O

AURORA CANNABIS INC. NOTICE OF CHANGE OF AUDITOR TO: KPMG LLP PO Box 10426, 777 Dunsmuir Street Vancouver, BC V7Y 1K3 AND TO: Alberta Securities Commission British Columbia Securities Commission Manitoba Securities Commission Saskatchewan Financial S

EX-99.1 Exhibit 99.1 AURORA CANNABIS INC. NOTICE OF CHANGE OF AUDITOR TO: KPMG LLP PO Box 10426, 777 Dunsmuir Street Vancouver, BC V7Y 1K3 AND TO: Alberta Securities Commission British Columbia Securities Commission Manitoba Securities Commission Saskatchewan Financial Services Commission Ontario Securities Commission Autorité des marchés financiers Financial and Consumer Services Commission (New

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File No. 001-38691 AURO

6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant’s name into English) 2207 90B St. SW Edmonton, Alberta Canada T6X 1V8 (Address of principal executive

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive o

Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]

Exhibit 99.1 Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1] NASDAQ | TSX: ACB EDMONTON, AB, Feb. 29, 2024 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canada-based leading global medical cannabis company, today announced that it has repaid an a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive o

Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation

Exhibit 99.1 Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation NASDAQ | TSX: ACB EDMONTON, AB, Feb. 20, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, is pleased to announce today that Simona King, a former executive of Bristol Myers-Squibb, a leadi

FORM 51-102F3 MATERIAL CHANGE REPORT

Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Aurora Cannabis Inc. (“Aurora” or the “Company”) 2207-90b Street SW Edmonton, Alberta T6X 1V8 Item 2 Date of Material Change February 7, 2024 Item 3 News Release A press release describing the material change was disseminated by Aurora on February 8, 2024 through Cision PR Newswire and can be found on SEDAR+ at ww

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW, Edmonton, Alberta, Canada T6X 1V8 (Address of principal executi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive o

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements For the three and nine months ended December 31, 2023 and 2022 (in Canadian Dollars)

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and nine months ended December 31, 2023 and 2022 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Loss and Comprehensive Loss 4 Condensed Consolidated Interim Statements of Changes in Equity 6 Conden

Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million

Exhibit 99.1 Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million NASDAQ | TSX: ACB Re-Affirms Commitment to Achieving Positive Free Cash Flow1 This Calendar Year, Delivers Fifth Consecutive Quarter of Positive Adjusted EBITDA1 Aurora Becomes the Largest Global Medical Cannabis Company in Nationally Legal Markets Following the Acquisition of

AURORA CANNABIS INC. Management’s Discussion & Analysis For the three and nine months ended December 31, 2023 and 2022 (in Canadian Dollars)

AURORA CANNABIS INC. Management’s Discussion & Analysis For the three and nine months ended December 31, 2023 and 2022 (in Canadian Dollars) Management’s Discussion & Analysis Table of Contents Business Overview 3 Condensed Statement of Comprehensive Loss 5 Key Quarterly Financial and Operating Results 6 Key Developments During and Subsequent to Three Months Ended December 31, 2023 7 Financial Rev

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive o

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “inter

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Glen Ibbott, Chief Financial Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Glen Ibbott, Chief Financial Officer of Aurora Cannabis Inc.

Aurora Cannabis Acquires MedReleaf Australia

Exhibit 99.1 Aurora Cannabis Acquires MedReleaf Australia NASDAQ | TSX: ACB Aurora becomes the largest global medical cannabis company operating in nationally legal markets. MedReleaf Australia holds the #2 position in medical cannabis within the rapidly growing ~AUD$400 million1 Australian market. Transaction is expected to be immediately accretive to Adjusted EBITDA2 and accelerate the Company's

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive of

Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call

Exhibit 99.1 Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call NASDAQ | TSX: ACB Re-affirms expectation of positive annual Adjusted EBITDA1 for fiscal 2024 and Positive Free Cash Flow1 generation in calendar 2024 Announces Intention to Consolidate Common Shares Q3 2024 Investor Conference call scheduled for February 8, 2024 at 8:

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Glen Ibbott, Chief Financial Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Glen Ibbott, Chief Financial Officer of Aurora Cannabis Inc.

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “inter

1 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc.

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements For the three and six months ended September 30, 2023 and 2022 (in Canadian Dollars)

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and six months ended September 30, 2023 and 2022 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Loss and Comprehensive Loss 4 Condensed Consolidated Interim Statements of Changes in Equity 6 Conden

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive o

AURORA CANNABIS INC. Management’s Discussion & Analysis For the three and six months September 30, 2023 and 2022 (in Canadian Dollars)

AURORA CANNABIS INC. Management’s Discussion & Analysis For the three and six months September 30, 2023 and 2022 (in Canadian Dollars) Management’s Discussion & Analysis Table of Contents Business Overview 3 Condensed Statement of Comprehensive Loss 5 Key Quarterly Financial and Operating Results 6 Key Developments During and Subsequent to Three Months Ended September 30, 2023 7 Financial Review 8

Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDA

Exhibit 99.1 Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDA NASDAQ | TSX: ACB • Delivers Record Positive Adjusted EBITDA1 of $3.4 Million • Quarterly Net Revenue1 rose 30% YoY to $63.4 Million; Strong Growth of 42% in Global Medical Cannabis • Net cash position of over $200 Million, Expects to Repay the Remaining US$5.3 Million Balance of

Aurora Cannabis to Host Second Quarter Fiscal Year 2024 Investor Conference Call

Exhibit 99.1 Aurora Cannabis to Host Second Quarter Fiscal Year 2024 Investor Conference Call NASDAQ | TSX: ACB EDMONTON, AB, Oct. 26, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2024 on Thu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File No. 001-38691

6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant’s name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executiv

Aurora Cannabis Inc. Announces Closing of its C$38.8 Million Bought Deal Financing, Including the Full Exercise of the Over-Allotment Option Intends to Repay Remaining Convertible Debt Balance, Saving Almost C$2 Million in Annual Interest Payments

EX-99.1 Exhibit 99.1 October 3, 2023 NASDAQ | TSX: ACB Aurora Cannabis Inc. Announces Closing of its C$38.8 Million Bought Deal Financing, Including the Full Exercise of the Over-Allotment Option Intends to Repay Remaining Convertible Debt Balance, Saving Almost C$2 Million in Annual Interest Payments Edmonton, AB – October 3, 2023 – Aurora Cannabis Inc. (“Aurora” or the “Company”) (NASDAQ | TSX:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File No. 001-3869

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant’s name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive

September 28, 2023  NASDAQ | TSX: ACB Aurora Cannabis Inc. Announces C$34 Million Bought Deal Financing Intends to Repay Remaining Convertible Debt Balance

Exhibit 99.1 September 28, 2023  NASDAQ | TSX: ACB Aurora Cannabis Inc. Announces C$34 Million Bought Deal Financing Intends to Repay Remaining Convertible Debt Balance Edmonton, AB – September 28, 2023 – Aurora Cannabis Inc. (“Aurora” or the “Company”) (NASDAQ | TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has entered into an agreement pursuant to which c

Aurora Confirms Approval of Transfer to Nasdaq Capital Market; Enters into Agreement to Repurchase a Further ~ US$9.6 Million Principal Amount of Convertible Notes

Exhibit 99.1 Aurora Confirms Approval of Transfer to Nasdaq Capital Market; Enters into Agreement to Repurchase a Further ~ US$9.6 Million Principal Amount of Convertible Notes NASDAQ | TSX: ACB EDMONTON, AB, Sept. 19, 2023 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has received appr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File No. 001-3869

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File No. 001-3869

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive

Aurora Repurchases ~US$9.0 Million Principal Amount of Convertible Notes; Continues Progress Towards Positive Free Cash Flow with less than ~US$39 Million of Notes Outstanding

Exhibit 99.1 Aurora Repurchases ~US$9.0 Million Principal Amount of Convertible Notes; Continues Progress Towards Positive Free Cash Flow with less than ~US$39 Million of Notes Outstanding NASDAQ | TSX: ACB EDMONTON, AB, Sept. 8, 2023 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has re

Aurora Cannabis Announces Results of 2023 Annual General Meeting

Exhibit 99.1 Aurora Cannabis Announces Results of 2023 Annual General Meeting NASDAQ | TSX: ACB EDMONTON, AB, Aug. 14, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, is pleased to announce the voting results from its Annual General Meeting of Shareholders (the "Meeting") held today, Monday, August 14, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File No. 001-38691 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive off

ANNUAL GENERAL MEETING OF SHAREHOLDERS OF AURORA CANNABIS INC. (the “Company”) August 14, 2023 REPORT OF VOTING RESULTS Pursuant to Section 11.3 of National Instrument 51-102 Continuous Disclosure Obligations (“NI 51-102”)

Exhibit 99.2 ANNUAL GENERAL MEETING OF SHAREHOLDERS OF AURORA CANNABIS INC. (the “Company”) August 14, 2023 REPORT OF VOTING RESULTS Pursuant to Section 11.3 of National Instrument 51-102 Continuous Disclosure Obligations (“NI 51-102”) In accordance with section 11.3 of NI 51-102 and following the annual general meeting of the holders of common shares (“Shares”) of the Company held on August 14, 2

Aurora Cannabis Announces Fiscal 2024 First Quarter Results, and Delivers Record Positive Adjusted EBITDA

Exhibit 99.1 Aurora Cannabis Announces Fiscal 2024 First Quarter Results, and Delivers Record Positive Adjusted EBITDA Achieves Quarterly Net Revenue1 of $75.1 Million; Strong YoY Growth Across All Business Units; Global Medical Cannabis +14%, Consumer Cannabis +5%, Plant Propagation +12% Delivers Third Sequential Quarter of Positive Adjusted EBITDA1, Supported by Bevo's Record Quarterly Revenue C

Form 52-109F2 Certification of Interim Filings Full Certificate

Exhibit 99.3 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Aurora Cannabis Inc. (the “issuer”) for the interim period ended June 30, 2023. 2. No misrepresentations: Based on my knowl

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements For the three months ended June 30, 2023 and 2022 (in Canadian Dollars)

Exhibit 99.1 AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three months ended June 30, 2023 and 2022 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Comprehensive Loss 4 Condensed Consolidated Interim Statements of Changes in Equity 6 Condensed Conso

AURORA CANNABIS INC. Management’s Discussion & Analysis For the three months ended June 30, 2023 and 2022 (in Canadian Dollars)

Exhibit 99.2 AURORA CANNABIS INC. Management’s Discussion & Analysis For the three months ended June 30, 2023 and 2022 (in Canadian Dollars) Management’s Discussion & Analysis Table of Contents Business Overview 3 Condensed Statement of Comprehensive Loss 5 Key Quarterly Financial and Operating Results 6 Key Developments During and Subsequent to Three Months Ended June 30, 2023 6 Financial Review

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File No. 001-38691 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive off

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File No. 001-38691 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue Leduc, Alberta,T9E 0G8 Canada (Address of principal executive offic

Form 52-109F2 Certification of Interim Filings Full Certificate

Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Glen Ibbott, Chief Financial Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Aurora Cannabis Inc. (the “issuer”) for the interim period ended June 30, 2023. 2. No misrepresentations: Based on my knowled

Aurora Cannabis to Host First Quarter Fiscal Year 2024 Investor Conference Call

Exhibit 99.1 Aurora Cannabis to Host First Quarter Fiscal Year 2024 Investor Conference Call NASDAQ| TSX: ACB EDMONTON, AB , July 27, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, announced today that it has scheduled a conference call to discuss the results for its first quarter fiscal year 2024 on Thurs

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive offic

Aurora Cannabis Announces Sale of Aurora Sun Facility to Bevo Expected to Provide Incremental Revenue and Cash Flow

Exhibit 99.1 Aurora Cannabis Announces Sale of Aurora Sun Facility to Bevo Expected to Provide Incremental Revenue and Cash Flow NASDAQ | TSX: ACB EDMONTON, AB, July 24, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, announced today that a wholly-owned subsidiary of the Company has closed the sale of its M

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive offic

Aurora's board of directors recommends that shareholders vote FOR all of the director nominees and meeting resolutions. Shareholders are encouraged to read the Circular and vote your shares as soon as possible. The deadline for voting your shares is

Exhibit 99.1 Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders Your vote is important no matter how many shares you own. Vote today. Shareholders who have questions or need assistance with voting their shares should contact Aurora Cannabis Inc.'s strategic advisor and proxy solicitation agent, Laur

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive offic

EX-99.4

Exhibit 99.4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive offic

A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER

Exhibit 99.1 A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER June 30, 2023 Dear shareholders, We are pleased to invite you to the 2023 Annual General Meeting of Shareholders (the “Meeting”) of Aurora Cannabis Inc. (“Aurora” or the “Company”) to be held on Monday, August 14, 2023 at 1:00 pm Eastern Time. We are holding the Meeting in a virtual-only format once again in order to give our shareholders an

Beneficial Shareholders Shares held with a broker, bank or other intermediary

Exhibit 99.3 Notice of Annual General Meeting of Shareholders and Availability of Proxy Materials To vote you must follow the methods reflected on your enclosed Voting Instruction Form (“VIF”) or Form of Proxy (“Proxy”) BEFORE 1:00 p.m. Eastern on Thursday, August 10, 2023 (or such earlier time specified in the VIF by the intermediary holding your shares) MEETING DATE AND LOCATION Meeting Type: An

EX-99.2

Exhibit 99.2

EX-99.5

Exhibit 99.5

CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Aurora Cannabis Inc. (the “Company”) on Form 40-F for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Miguel Martin, Chief Executive Officer of the Company, certify, pursuan

AURORA CANNABIS INC. Consolidated Financial Statements For the nine months ended March 31, 2023 and year ended June 30, 2022 (in Canadian Dollars)

AURORA CANNABIS INC. Consolidated Financial Statements For the nine months ended March 31, 2023 and year ended June 30, 2022 (in Canadian Dollars) Management’s Responsibility To the Shareholders of Aurora Cannabis Inc.: Management is responsible for the preparation and presentation of the consolidated financial statements and accompanying note disclosures in accordance with International Financial

AURORA CANNABIS INC. Management’s Discussion & Analysis For the nine months ended March 31, 2023 and year ended June 30, 2022 (in Canadian Dollars)

AURORA CANNABIS INC. Management’s Discussion & Analysis For the nine months ended March 31, 2023 and year ended June 30, 2022 (in Canadian Dollars) Management’s Discussion & Analysis Table of Contents Business Overview 3 Condensed Statement of Comprehensive Loss 5 Key Quarterly Financial and Operating Results 5 Key Developments During and Subsequent to Three Months Ended March 31, 2023 6 Financial

Consent of Independent Registered Public Accounting Firm

Consent of Independent Registered Public Accounting Firm The Board of Directors Aurora Cannabis Inc.

CERTIFICATION

CERTIFICATION I, Glen Ibbott, certify that: 1. I have reviewed this annual report on Form 40-F of Aurora Cannabis Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period co

CERTIFICATION

CERTIFICATION I, Miguel Martin, certify that: 1. I have reviewed this annual report on Form 40-F of Aurora Cannabis Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 x ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 x ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the nine month fiscal period ended March 31, 2023 Commission File Number: 001-38691 AURORA CANNABIS INC. (Exact name of Registrant as spe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File No. 001-38691 AUR

6-K 1 aurora6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address

Aurora Cannabis Announces Fiscal 2023 Third Quarter and Files Full Year Results

Exhibit 99.1 Aurora Cannabis Announces Fiscal 2023 Third Quarter and Files Full Year Results NASDAQ | TSX: ACB Achieves Second Sequential Quarter of Positive Adjusted EBITDA1 Net Revenue Reaches $64 Million, Increasing 4% Sequentially and 27% YoY; Driving Adjusted Gross Profit1 of $30.6 Million Balance Sheet Remains Strong With a Cash Position of ~$230 Million Cash on Hand with ~$80 Million of Con

CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Aurora Cannabis Inc. (the “Company”) on Form 40-F for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Glen Ibbott, Chief Financial Officer of the Company, certify, pursuant

{00239068:2} ANNUAL INFORMATION FORM For the nine-month financial period ended March 31, 2023 June 14, 2023 Opening the World to Cannabis. Enabled by Science. Empowered by People. For Patients & Consumers. {00239068:2} WHAT’S INSIDE: FORWARD-LOOKING

a997-aif {00239068:2} ANNUAL INFORMATION FORM For the nine-month financial period ended March 31, 2023 June 14, 2023 Opening the World to Cannabis.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File No. 001-38691 AUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive offic

Aurora Cannabis to Host Third Quarter and Fiscal Year 2023 Investor Conference Call and File Related Year End Information

Exhibit 99.1 Aurora Cannabis to Host Third Quarter and Fiscal Year 2023 Investor Conference Call and File Related Year End Information NASDAQ | TSX: ACB EDMONTON, AB, June 7, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, announced today that it has scheduled a conference call to discuss the results for it

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023 Commission File No. 001-38691 AURO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive office

Vancouver BC, V6C 3B9

Exhibit 99.1 May 25, 2023 510 Burrard St, 3rd Floor Vancouver BC, V6C 3B9 www.computershare.com To: All Canadian Securities Regulatory Authorities NASDAQ Exchange Subject: AURORA CANNABIS INC. Dear Sir/Madam: We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: Meeting Type : Annual General Meeting Record Date for Notice of Meeting : June 19,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File No. 001-38691 AU

6-K 1 aurora6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 500-10355 Jasper Avenue, Edmonton, Alberta, Canada T5J

Aurora Expands Medical Cannabis Portfolio in Germany: New flower varieties for patients with high THC needs

Exhibit 99.1 Aurora Expands Medical Cannabis Portfolio in Germany: New flower varieties for patients with high THC needs NASDAQ | TSX: ACB EDMONTON, AB, April 28, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and a leading manufacturer and supplier of dried flower for medical patients worldwide, today ann

PROSPECTUS SUPPLEMENT TO THE SHORT FORM BASE SHELF PROSPECTUS DATED APRIL 27, 2023 New Issue April 27, 2023 AURORA CANNABIS INC. 11,125,000 Common Shares

Table of Contents Filed pursuant to General Instruction II.L of Form F-10; File No. 333-271479 PROSPECTUS SUPPLEMENT TO THE SHORT FORM BASE SHELF PROSPECTUS DATED APRIL 27, 2023 New Issue April 27, 2023 AURORA CANNABIS INC. 11,125,000 Common Shares This Prospectus Supplement relates to: (i) up to 11,125,000 common shares (the “Warrant Shares”) of Aurora Cannabis Inc. (“we”, “our”, “Aurora” or the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File No. 001-38691 AU

6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant’s name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive

PROSPECTUS SUPPLEMENT TO THE SHORT FORM BASE SHELF PROSPECTUS DATED APRIL 27, 2023 New Issue April 27, 2023 AURORA CANNABIS INC. 70,408,750 Common Shares

Table of Contents Filed pursuant to General Instruction II.L of Form F-10; File No. 333-271479 PROSPECTUS SUPPLEMENT TO THE SHORT FORM BASE SHELF PROSPECTUS DATED APRIL 27, 2023 New Issue April 27, 2023 AURORA CANNABIS INC. 70,408,750 Common Shares This Prospectus Supplement relates to: (i) up to 70,408,750 common shares (the “Warrant Shares”) of Aurora Cannabis Inc. (“we”, “our”, “Aurora” or the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. Name of issuer or person filing (“Filer”): Aurora Cannabis Inc. B. (1)   This is [check one]: ☒   an origi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. Name of issuer or person filing (“Filer”): Aurora Cannabis Inc. B. (1)   This is [check one]: ☒   an original filing for the Filer ☐   an amended filing for the Filer (2)   Check the following box if you are filing the Form F-X in paper in accordance with

PROSPECTUS SUPPLEMENT TO THE SHORT FORM BASE SHELF PROSPECTUS DATED APRIL 27, 2023 New Issue April 27, 2023 AURORA CANNABIS INC. 6,600,000 Common Shares

SUPPL Table of Contents Filed pursuant to General Instruction II.L of Form F-10; File No. 333-271479 PROSPECTUS SUPPLEMENT TO THE SHORT FORM BASE SHELF PROSPECTUS DATED APRIL 27, 2023 New Issue April 27, 2023 AURORA CANNABIS INC. 6,600,000 Common Shares This Prospectus Supplement relates to: (i) up to 6,600,000 common shares (the “Warrant Shares”) of Aurora Cannabis Inc. (“we”, “our”, “Aurora” or

Calculation of Filing Fee Tables.

Exhibit 107 CALCULATION OF FILING FEE TABLES Form F-10 (Form Type) Aurora Cannabis Inc.

Statement of Eligibility of the Trustee for the Indenture referenced in Exhibit 7.1, Computershare Trust Company, N.A., on Form T-1.

EX-7.2 Exhibit 7.2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of trustee as specified in its char

Powers of Attorney (included on the signature page of this Registration Statement).

F-10 Table of Contents As filed with the Securities and Exchange Commission on April 27, 2023 Registration No.

Aurora Repurchases ~$22 Million Principal Amount of Convertible Notes, Saving $1.2 Million in Annualized Interest Payments and Leaving ~$79 Million (US$59) of Notes Outstanding; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry

Exhibit 99.1 Aurora Repurchases ~$22 Million Principal Amount of Convertible Notes, Saving $1.2 Million in Annualized Interest Payments and Leaving ~$79 Million (US$59) of Notes Outstanding; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry NASDAQ | TSX: ACB EDMONTON, AB, April 24, 2023 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadia

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File No. 001-38691 AU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 500-10355 Jasper Avenue, Edmonton, Alberta, Canada T5J 1Y6 (Address of principal ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File No. 001-38691 AU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 500-10355 Jasper Avenue, Edmonton, Alberta, Canada T5J 1Y6 (Address of principal ex

Aurora Repurchases ~$47 Million Principal Amount of Convertible Notes, Saving $2.6 Million in Annualized Interest Payments; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry

Exhibit 99.1 Aurora Repurchases ~$47 Million Principal Amount of Convertible Notes, Saving $2.6 Million in Annualized Interest Payments; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry NASDAQ | TSX: ACB EDMONTON, AB, March 30, 2023 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announc

Aurora Provides Update on Nasdaq Listing

Exhibit 99.1 Aurora Provides Update on Nasdaq Listing NASDAQ | TSX: ACB EDMONTON, AB, March 24, 2023 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced receipt of a notification letter (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") dated March 24, 2023, advising that the Com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File No. 001-38691 AU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 500-10355 Jasper Avenue, Edmonton, Alberta, Canada T5J 1Y6 (Address of principal ex

Aurora Cannabis Announces Filing of Preliminary Base Shelf Prospectus

Exhibit 99.1 Aurora Cannabis Announces Filing of Preliminary Base Shelf Prospectus NASDAQ | TSX: ACB EDMONTON, AB, March 17, 2023 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced it has filed a new preliminary short form base shelf prospectus (the "Base Shelf Prospectus") with securities regulator

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File No. 001-38691 AU

6-K 1 aurora6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 500-10355 Jasper Avenue, Edmonton, Alberta, Canada T5J

Canada's leading medical cannabis provider and Australia's preeminent medical cannabis supplier to bring three new premium strains to Australian patients

Exhibit 99.1 Aurora and MedReleaf Australia Launch new Medical Cannabis Brand - CraftPlant NASDAQ | TSX: ACB Canada's leading medical cannabis provider and Australia's preeminent medical cannabis supplier to bring three new premium strains to Australian patients EDMONTON, AB, Feb. 22, 2023 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, an

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 500-10355 Jasper Avenue, Edmonton, Alberta, Canada T5J 1Y6 (Address of principal

ACB / Aurora Cannabis Inc. / CVI Investments, Inc. - SC 13G/A Passive Investment

SC 13G/A 1 tm235037d7sc13ga.htm SC 13G/A CUSIP No: 05156X884 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2. (Amendment No. 1)* Aurora Cannabis Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securiti

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 500-10355 Jasper Avenue, Edmonton, Alberta, Canada T5J 1Y6 (Address of principal

Form 52-109F2 Certification of Interim Filings Full Certificate

EX-99.4 5 ex994.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Glen Ibbott, Chief Financial Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Aurora Cannabis Inc. (the “issuer”) for the interim period ended

Form 52-109F2 Certification of Interim Filings Full Certificate

Exhibit 99.3 Form 52-109F2 Certification of Interim Filings Full Certificate I, Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Aurora Cannabis Inc. (the “issuer”) for the interim period ended December 31, 2022. 2. No misrepresentations: Based on my k

AURORA CANNABIS INC. Interim Management’s Discussion & Analysis (Unaudited) For the three and six months ended December 31, 2022 and 2021 (in Canadian Dollars)

Exhibit 99.2 AURORA CANNABIS INC. Interim Management’s Discussion & Analysis (Unaudited) For the three and six months ended December 31, 2022 and 2021 (in Canadian Dollars) Interim Management’s Discussion & Analysis Table of Contents Business Overview 3 Condensed Statement of Comprehensive Loss 7 Key Quarterly Financial and Operating Results 7 Key Developments During and Subsequent to the Three Mo

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and six months ended December 31, 2022 and 2021 (in Canadian Dollars)

Exhibit 99.1 AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and six months ended December 31, 2022 and 2021 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Comprehensive Loss 4 Condensed Consolidated Interim Statements of Changes in Equity 6 Con

Aurora Cannabis Announces Fiscal 2023 Second Quarter Results

Exhibit 99.1 Aurora Cannabis Announces Fiscal 2023 Second Quarter Results NASDAQ | TSX: ACB Cannabis Revenues Up ~20% from Fiscal Q1 2023, Net Revenue1 of $61.7 Million Achieves Positive Adjusted EBITDA1 in Line with Prior Guidance Delivers ~$340 Million in Annualized Cost Savings Since February 2020 Balance Sheet Remains in Net Cash Position, Among Strongest in Industry; Debt Reduction of ~$302 M

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File No. 001-38691

6-K 1 aurora6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 500-10355 Jasper Avenue, Edmonton, Alberta, Canada T

Aurora Cannabis to Host Second Quarter Fiscal Year 2023 Investor Conference Call

Exhibit 99.1 Aurora Cannabis to Host Second Quarter Fiscal Year 2023 Investor Conference Call EDMONTON, AB, Jan. 26, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2023 on Thurs

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 500-10355 Jasper Avenue, Edmonton, Alberta, Canada T5J 1Y6 (Address of principal

Aurora Cannabis Announces Sale of Polaris Facility - Balance Sheet Remains Among Strongest in Industry

EX-99.1 2 ex991.htm NEWS RELEASE DATED JANAURY 4, 2023 Exhibit 99.1 Aurora Cannabis Announces Sale of Polaris Facility - Balance Sheet Remains Among Strongest in Industry NASDAQ | TSX: ACB EDMONTON, AB, Jan. 4, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that the Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File No. 001-38691

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 500-10355 Jasper Avenue, Edmonton, Alberta, Canada T5J 1Y6 (Address of principal

Balance Sheet Remains in Net Cash Position, Further Strengthened with Accretive Debt Reduction

Exhibit 99.1 Aurora Cannabis Repurchases ~$103 Million Principal Amount of Convertible Notes; Balance Sheet Among Strongest in Industry NASDAQ | TSX: ACB Balance Sheet Remains in Net Cash Position, Further Strengthened with Accretive Debt Reduction EDMONTON, AB, Dec. 5, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2022 Commission File No. 001-38691

6-K 1 aurora6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2022 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 500-10355 Jasper Avenue, Edmonton, Alberta, Canada T

AURORA CANNABIS INC. - and - COMPUTERSHARE TRUST COMPANY OF CANADA WARRANT INDENTURE Providing for the Issue of up to 11,500,000 Warrants November 16, 2020

EX-99.1 Exhibit 99.1 AURORA CANNABIS INC. - and - COMPUTERSHARE TRUST COMPANY OF CANADA WARRANT INDENTURE Providing for the Issue of up to 11,500,000 Warrants November 16, 2020 TABLE OF CONTENTS Page ARTICLE 1 INTERPRETATION 2 1.1   Definitions 2 1.2   Words Importing the Singular 6 1.3   Interpretation not Affected by Headings 6 1.4   Day not a Business Day 7 1.5   Time of the Essence 7 1.6   Gov

AURORA CANNABIS INC. - and - COMPUTERSHARE TRUST COMPANY OF CANADA WARRANT INDENTURE Providing for the Issue of up to 6,600,000 Warrants January 26, 2021

EX-99.2 Exhibit 99.2 AURORA CANNABIS INC. - and - COMPUTERSHARE TRUST COMPANY OF CANADA WARRANT INDENTURE Providing for the Issue of up to 6,600,000 Warrants January 26, 2021 TABLE OF CONTENTS Page ARTICLE 1 INTERPRETATION 2 1.1 Definitions 2 1.2 Words Importing the Singular 6 1.3 Interpretation not Affected by Headings 6 1.4 Day not a Business Day 7 1.5 Time of the Essence 7 1.6 Governing Law 7 1

November 25, 2022

EX-99.3 Exhibit 99.3 November 25, 2022 VIA EDGAR Aurora Cannabis Inc. 500-10355 Jasper Avenue Edmonton, AB T5J 1Y6 Re: Prospectus supplements dated November 25, 2022 (the “Prospectus Supplements”) to short form base shelf prospectus dated March 29, 2021 of Aurora Cannabis Inc. (the “Issuer”), forming a part of the registration statement on Form F-10 (File No. 333-254096) of the Issuer Dear Sirs/Me

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File No. 001-38691

6-K 1 d425791d6k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant’s name into English) 500-10355 Jasper Avenue, Edmonton, Alberta, Canada T5J

PROSPECTUS SUPPLEMENT TO THE SHORT FORM BASE SHELF PROSPECTUS DATED MARCH 29, 2021 New Issue November 25, 2022 AURORA CANNABIS INC. 11,125,000 Common Shares

Table of Contents Filed pursuant to General Instruction II.L of Form F-10; File No. 333-254096 PROSPECTUS SUPPLEMENT TO THE SHORT FORM BASE SHELF PROSPECTUS DATED MARCH 29, 2021 New Issue November 25, 2022 AURORA CANNABIS INC. 11,125,000 Common Shares This Prospectus Supplement relates to: (i) up to 11,125,000 common shares (the ?Warrant Shares?) of Aurora Cannabis Inc. (?we?, ?our?, ?Aurora? or t